Evidence map›Paper›PMID 31315280›Full record

ArticleBioengineering (Basel, Switzerland)2019

3D Printing High-Consistency Enzymatic Nanocellulose Obtained from a Soda-Ethanol-O

Heli Kangas, Fernando E Felissia, Daniel Filgueira, Nanci V Ehman, María E Vallejos, Camila M Imlauer, Panu Lahtinen, María C Area, And Gary Chinga-Carrasco

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Biocomposite Inks for 3D Printing.Bioengineering (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heli KangasVTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 VTT, Finland. heli.Kangas@vtt.fi.
Fernando E FelissiaInstituto de Materiales de Misiones (IMAM), Félix de Azara 1552, (3300) Posadas, Misiones, Argentina.
Daniel FilgueiraRISE PFI, Høgskoleringen 6b, 7491 Trondheim, Norway.
Nanci V EhmanInstituto de Materiales de Misiones (IMAM), Félix de Azara 1552, (3300) Posadas, Misiones, Argentina.
María E VallejosInstituto de Materiales de Misiones (IMAM), Félix de Azara 1552, (3300) Posadas, Misiones, Argentina.
Camila M ImlauerInstituto de Materiales de Misiones (IMAM), Félix de Azara 1552, (3300) Posadas, Misiones, Argentina.
Panu LahtinenVTT Technical Research Centre of Finland Ltd, P.O. Box 1000, FI-02044 VTT, Finland.
María C AreaInstituto de Materiales de Misiones (IMAM), Félix de Azara 1552, (3300) Posadas, Misiones, Argentina. cristinaarea@gmail.com.
And Gary Chinga-CarrascoRISE PFI, Høgskoleringen 6b, 7491 Trondheim, Norway. gary.chinga.carrasco@rise-pfi.no.

Funding

BIOPHYSICS OF INFLUENZA HEMAGGLUTININ-MEDIATED FUSIONR03TW000715 · FIC · RUSH UNIVERSITY MEDICAL CENTER · PI COHEN, FREDRIC S · 1996 to 2001
$79k
Academy of Finland Agreement No. 311973Consejo Nacional de Investigaciones Científicas y Técnicas ELAC2015/T03-0715ERANet-LAC Grant ELAC2015/T03-0715Research Council of Norway Grant no. 271054
6 · The paper itself

Abstract

Soda-ethanol pulps, prepared from a forestry residue pine sawdust, were treated according to high-consistency enzymatic fibrillation technology to manufacture nanocellulose. The obtained nanocellulose was characterized and used as ink for three-dimensional (3D) printing of various structures. It was also tested for its moisture sorption capacity and cytotoxicity, as preliminary tests for evaluating its suitability for wound dressing and similar applications. During the high-consistency enzymatic treatment it was found that only the treatment of the O

Indexed as

3D printingcytotoxicitynanocellulosepine sawdustsoda ethanol pulping

Identifiers

PMID31315280
PMCPMC6783906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.